IAVI 006

Status:Completed

Phase:I/II

Principal Investigator(s):John Warin Ward

Objective:Evaluate and compare the safety and immunogenicity of two doses of candidate HIV-1 clade A DNA vaccine and a candidate HIV-1 clade A MVA vaccine.

Prevention Option(s):HIV Vaccine

Study Design:

Arms and Assigned Interventions

DescriptionTwo doses of candidate HIV-1 clade A DNA vaccine versus a placebo followed by a candidate HIV-1 clade A MVA vaccine or placebo.

Mode of DeliveryIntramuscular

ARMsExperimental

Official Code: IAVI 006

Trial Sponsors: IAVI, John Warin Ward, Medical Research Council (MRC), St. Mary's Hospital

Start Date

End Date

none

Enrollment:120

Age range: ↔ any

Population:

Stay up-to-date!